Investing.com - Pfizer reported on Tuesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Pfizer announced earnings per share of $0.93 on revenue of $14.58B. Analysts polled by Investing.com anticipated EPS of $0.7773 on revenue of $13.67B.
Pfizer shares are up 8% from the beginning of the year , still down 7.42% from its 52 week high of $43.02 set on Wednesday, December 9, 2020. They are under-performing the S&P Global 100 which is up 9.42% year to date.
Pfizer follows other major Healthcare sector earnings this month
Pfizer's report follows an earnings beat by J&J on Tuesday, April 20, 2021, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.
Novartis ADR had missed expectations on Tuesday, April 27, 2021 with first quarter EPS of $1.52 on revenue of $12.41B, compared to forecast for EPS of $1.54 on revenue of $12.5B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar